Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $12.5
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $20 to $12.5.
Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $20 to $12.5.